| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/31/2001 | CN1061346C Diazabicycloalkene derivatives and use, and drug composition containing said derivatives |
| 01/30/2001 | US6180791 Synthesis of 8-substituted xanthines |
| 01/30/2001 | US6180671 Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected |
| 01/30/2001 | US6180650 Antiinflammatory agents; respiratory system disorders; skin disorders; antitumor agents |
| 01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
| 01/30/2001 | US6180637 Therapy for parkinson, alzheimer disease |
| 01/30/2001 | US6180635 Novel thieno(2,3-d)pyrimidinediones which exhibit pharmacological activity, in particular immunosuppressive activity; treating allograft rejection |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180384 Compounds |
| 01/30/2001 | US6180136 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 01/30/2001 | CA2191352C Quinoline derivatives as tachykinin nk3 receptor antagonists |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005974A2 The il-1l1 gene and polypeptide products |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005958A1 Antisense modulation of p13 kinase p110 delta expression |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005823A2 Tryptase inhibitor |
| 01/25/2001 | WO2001005783A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | WO2001005782A1 Novel diphenyl-piperidine derivate |
| 01/25/2001 | WO2001005773A1 Conjugates of sodium channel blockers and methods of using the same |
| 01/25/2001 | WO2001005771A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | WO2001005770A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | WO2001005751A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005749A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005746A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005745A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005744A1 Novel aminobenzophenones |
| 01/25/2001 | WO2001005743A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
| 01/25/2001 | WO2001005420A1 Small peptides and methods for downregulation of ige |
| 01/25/2001 | WO2001005378A1 Ambroxol-containing lozenge |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000058465A3 Flint polypeptide analogs |
| 01/25/2001 | WO2000056360A3 Vaccine against antigens from bacteriae |
| 01/25/2001 | DE19933421A1 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate 2-benzyl-3-dimethylamino-1-phenyl-propanderi- derivatives |
| 01/25/2001 | DE19933164A1 Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with 5,6-substituted pyrimidine ring, their preparation and use as endothelin receptor antagonists |
| 01/25/2001 | DE19933148A1 Ambroxolhaltige Lutschtablette Ambroxol lozenge |
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2379627A1 Inhibitor proteins |
| 01/25/2001 | CA2379554A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | CA2379545A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | CA2379323A1 Small peptides and methods for downregulation of ige |
| 01/25/2001 | CA2379319A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379316A1 Novel aminobenzophenones |
| 01/25/2001 | CA2379293A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379286A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379273A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379064A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | CA2378954A1 The il-1l1 gene and polypeptide products |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378723A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
| 01/25/2001 | CA2378181A1 Conjugates of sodium channel blockers and methods of using the same |
| 01/25/2001 | CA2378084A1 Novel diphenyl-piperidine derivate |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/24/2001 | EP1070711A2 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| 01/24/2001 | EP1070710A2 Dithiolan derivatives, their preparation and their therapeutic effect |
| 01/24/2001 | EP1070502A2 Compositions and methods for treating or preventing inflammatory diseases |
| 01/24/2001 | EP1070069A1 Bicyclic hydroxamic acid derivatives |
| 01/24/2001 | EP1070058A1 (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/24/2001 | EP1070056A1 Phthalazinone pde iii/iv inhibitors |
| 01/24/2001 | EP1069887A1 Aerosol composition |
| 01/24/2001 | EP0788513B1 Use of binding agents to cd23 in the treatment of autoimmune diseases |
| 01/24/2001 | CN1281458A Purine compounds having PDE IV inhibitory activity and methods of synthesis |
| 01/24/2001 | CN1281447A (i(E))-3-[1-i(n)-butyl-5-[2-(-carboxyphenyl) methoxy-4-chlorophenyl]-1i(H)-pyrazol-4-yl]-2-[(5-methoxy-2,3-dihydrobenzofuran-6-yl) methyl]-prop-2-enoic acid monoargininyl salt |
| 01/24/2001 | CN1281441A Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors |
| 01/24/2001 | CN1281432A Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing same |
| 01/24/2001 | CN1281430A N-alkanoylphenylalanine derivatives |
| 01/24/2001 | CN1281367A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 01/24/2001 | CN1281360A Use of substituted amidino compounds in treatment of chronic obstructive pulmonary disease |
| 01/24/2001 | CN1280839A Chinese-medicinal nose drops for treating acute or chronic rhinitis and its preparing process |
| 01/24/2001 | CN1061044C Tricyclic 5,6-dihydro-9H-pyrazolo [3,4-C]-1,2,4-triaolo [4,3-alpha] pyridines |
| 01/23/2001 | US6177470 Prostaglandin synthesis |
| 01/23/2001 | US6177429 Dihydropyrazine derivatives as NPY antagonists |
| 01/23/2001 | US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis |
| 01/23/2001 | US6177426 Morpholino-N-ethyl ester prodrugs of indole sPLA2 inhibitors |
| 01/23/2001 | US6177425 Stereospecific enantiomer having antiinflammatory and neutrophil elastase inhibiting activity; for treatment of chronic bronchitis in humans or animals |
| 01/23/2001 | US6177419 Antioxidant chelate compounds for preventing oxygen free radical-associated diseases in mammals; neuroprotectants, superoxide dismutase (sod), catalase (cat) and/or peroxidase (pod) mimetics |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177096 Water soluble film for oral administration with instant wettability |
| 01/23/2001 | CA2191790C Biaromatic compounds containing an adamantyl group in para position; pharmaceutical and cosmetic compositions containing them and use thereof |
| 01/21/2001 | CA2314373A1 Heteroaryl-substituted pyrrole derivatives, their preparation and their thereapeutic uses |
| 01/18/2001 | WO2001004335A2 Human-bovine chimeric respiratory syncytial virus vaccines |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001004271A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004124A1 OXATHIEPINO[6,5-b]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 01/18/2001 | WO2001004118A2 Quinuclidine derivatives and their use as muscarinic m3 receptor ligands |
| 01/18/2001 | WO2001004111A1 Anilinoquinazolines as protein tyrosine kinase inhibitors |
| 01/18/2001 | WO2001004099A1 Benzoylpyridazines |
| 01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | WO2001003696A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 01/18/2001 | WO2001003688A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 01/18/2001 | WO2001003669A2 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 01/18/2001 | WO2000063415A8 Dna encoding the human vanilloid receptor vr1 |
| 01/18/2001 | WO2000063234A3 Pyrrolidincarbonylamino cyclic disulfides as vcam-vla4 antagonists |
| 01/18/2001 | WO2000047215A3 Methods for anti-tumor therapy |